Peer reviewed
Metformin and aging: A clinical review
Clinical review summarizing metformin's proposed mechanisms (AMPK activation, mTOR inhibition, insulin sensitization) and the evidence base for and against its use as a geroprotective agent.
Aging and Disease / Metabolism reviewsPublished 2021-01-01Accessed 2026-07-01
Registry record
Source metadata
- Publisher
- Aging and Disease / Metabolism reviews
- Source type
- Peer reviewed
- Registry ID
choi-2021-metformin-metabolism-review
Source usage
Linked from 2 pages
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.